Pain Medicine Doctors in Bedford, TX Accepting Medicare

4 Pain Medicine doctors found. Showing 1 - 4

Dr. Rodolfo Alberto Herrera, M.D. Pain Medicine - Interventional Pain Medicine Medicare: Accepting Medicare Assignments Practice Location: 1305 Airport Fwy Ste 302, Bedford, TX 76021 Phone: 817-283-6995    Fax: 817-952-7011

Dr. Jerry Michael Stanton, D.O. Pain Medicine - Interventional Pain Medicine Medicare: Accepting Medicare Assignments Practice Location: 1600 Central Dr, Suite 160, Bedford, TX 76022 Phone: 817-268-0104    Fax: 817-268-6102

Glenn Eugene Hansen, D.O, Pain Medicine - Pain Medicine Medicare: Accepting Medicare Assignments Practice Location: 2520 Harwood Rd, Suite 200, Bedford, TX 76021 Phone: 817-267-6222

Dr. Patrick Kevin Stanton, D.O. Pain Medicine - Interventional Pain Medicine Medicare: Accepting Medicare Assignments Practice Location: 1600 Central Dr, Suite 160, Bedford, TX 76022 Phone: 817-268-0104    Fax: 817-268-6102

News Archive

NCATS funds collaboration initiative aimed at repurposing antimalarial to combat Ebola virus

The National Center for Advancing Translational Sciences recently awarded $596,533.00 to Collaborations Pharmaceuticals, Inc. to initiate a partnership with Texas Biomedical Research Institute aimed at repurposing an antimalarial for use against the Ebola virus.

Experts gather at Cardiology 2015 conference to discuss challenges in treating congenital heart disease

Many aspects of pediatric cardiology are relatively new to the discipline. Only recently have physicians been able to accurately diagnose and characterize the myriad congenital cardiovascular conditions that occur and begin to apply successful strategies for care. This week, an international group of more than 800 medical experts gather at the nation's largest pediatric cardiology conference to discuss challenges in treating congenital heart disease in the fetus, neonates, children and young adults.

Synexus completes CT327 phase II psoriasis trial for Creabilis

Synexus has completed a phase II study for the European biotech, Creabilis, recruiting 26 patients in the UK to the psoriasis trial of its CT327 lead product in just 2 weeks, as part of an international proof-of-concept study. The company delivered the targeted number of patients well within the agreed timelines and budget.

This winter, protect your family from radon gas

This time of year might feel too late for making New Year's resolutions, or too early for spring cleaning, but it's just the right time for taking an important step to protect the health your family: testing your home for radon, the second-leading cause of lung cancer.

Johns Hopkins researchers identify new way to lower blood pressure in obese patients

There's no question that as body weight increases, so too does blood pressure. Now, in a study of mice, Johns Hopkins researchers have revealed exactly which molecules are likely responsible for the link between obesity and blood pressure.

Read more Medical News

› Verified 8 days ago